| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |